Cargando…
Hyaluronan Inhibition as a Therapeutic Target for Diabetic Kidney Disease: What Is Next?
Diabetic kidney disease (DKD) is the leading cause of CKD and ESKD in the United States and worldwide. Pharmacotherapy and lifestyle modifications for glycemia, dyslipidemia, and BP control have shown success in slowing the progression of DKD. Traditional treatments, such as angiotensin-converting e...
Autores principales: | Salman, Loay, Martinez, Laisel, Faddoul, Geovani, Manning, Christina, Ali, Karim, Salman, Maya, Vazquez-Padron, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Nephrology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371374/ https://www.ncbi.nlm.nih.gov/pubmed/37055910 http://dx.doi.org/10.34067/KID.0000000000000126 |
Ejemplares similares
-
A Multicenter Randomized Clinical Trial of Hemodialysis Access Blood Flow Surveillance Compared to Standard of Care: The Hemodialysis Access Surveillance Evaluation (HASE) Study
por: Salman, Loay, et al.
Publicado: (2020) -
Vein morphometry in end-stage kidney disease: Teasing out the contribution of age, comorbidities, and vintage to chronic wall remodeling
por: Labissiere, Xochilt, et al.
Publicado: (2022) -
Age-related changes in monocytes exacerbate neointimal hyperplasia after vascular injury
por: Martinez, Laisel, et al.
Publicado: (2015) -
Syndrome of Inappropriate Antidiuretic Hormone Secretion as a Presentation of Untreated Parkinson’s Disease
por: Ali, Karim, et al.
Publicado: (2023) -
An atypical case of hemodialysis access stent migration
por: Duque, Juan C., et al.
Publicado: (2022)